Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration
Ajit Magadum, Neha Singh, Ann Kurian, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 13, pp. 133-143
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration
Ajit Magadum, Neha Singh, Ann Kurian, et al.
Circulation (2020) Vol. 141, Iss. 15, pp. 1249-1265
Open Access | Times Cited: 217
Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response
Ana Catarina Silva, Cassilda Pereira, Ana Catarina R.G. Fonseca, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 153
Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction
Axelle Bois, Catarina Grandela, James Gallant, et al.
npj Regenerative Medicine (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
mRNA-Based Protein Replacement Therapy for the Heart
Ajit Magadum, Keerat Kaur, Lior Zangi
Molecular Therapy (2018) Vol. 27, Iss. 4, pp. 785-793
Open Access | Times Cited: 135
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction
Yoav Hadas, Adam Vincek, Elias Youssef, et al.
Circulation (2020) Vol. 141, Iss. 11, pp. 916-930
Open Access | Times Cited: 124
Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
Martijn J.W. Evers, Wenjuan Du, Qiangbing Yang, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 207-216
Open Access | Times Cited: 62
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115302-115302
Open Access | Times Cited: 12
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 10
Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration
M. Clara I. Labonia, Mariona Estapé Sentí, Petra H. van der Kraak, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 734-745
Open Access | Times Cited: 9
Therapies to prevent post-infarction remodelling: From repair to regeneration
Paolo Contessotto, Abhay Pandit
Biomaterials (2021) Vol. 275, pp. 120906-120906
Open Access | Times Cited: 42
Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI
Xuefeng Ai, Bingqian Yan, Nevin Witman, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 211-229
Open Access | Times Cited: 31
Regulation of endogenous cardiomyocyte proliferation: The known unknowns
Ilaria Secco, Mauro Giacca
Journal of Molecular and Cellular Cardiology (2023) Vol. 179, pp. 80-89
Open Access | Times Cited: 22
Modified mRNA as a Therapeutic Tool for the Heart
Keerat Kaur, Lior Zangi
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 6, pp. 871-880
Open Access | Times Cited: 41
mRNA, a Revolution in Biomedicine
Bruno Baptista, Rita Carapito, Nabila Laroui, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2090-2090
Open Access | Times Cited: 38
Biologics and their delivery systems: Trends in myocardial infarction
Matthew A. Borrelli, Hēth Turnquist, Steven R. Little
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 181-215
Open Access | Times Cited: 36
Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
Raj Kishore, Ajit Magadum
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 2, pp. 38-38
Open Access | Times Cited: 5
Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy
Yoav Hadas, Nishat Sultana, Elias Youssef, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 14, pp. 300-305
Open Access | Times Cited: 38
Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury
Nishat Sultana, Yoav Hadas, Mohammad Tofael Kabir Sharkar, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 17, pp. 622-633
Open Access | Times Cited: 34
Molecular functions of FSTL1 in the osteoarthritis
Wen‐Cui Li, Murad Alahdal, Zhiqin Deng, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106465-106465
Open Access | Times Cited: 33
Delivery of synthetic mRNAs for tissue regeneration
Heidrun Steinle, Marbod Weber, Sandra Stoppelkamp, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114007-114007
Closed Access | Times Cited: 31
The clinical progress and challenges of mRNA vaccines
Meng‐Zhen Yu, Nannan Wang, Jiaqing Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 11
New Types of Post-Translational Modification of Proteins in Cardiovascular Diseases
Juntao Fang, Shaoyu Wu, Hengli Zhao, et al.
Journal of Cardiovascular Translational Research (2025)
Open Access
Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart
Kazuma Handa, Masashi Kawamura, Masao Sasai, et al.
Journal of Controlled Release (2025), pp. 113623-113623
Open Access
mRNA therapy: A new frontier in regenerative medicine
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
Modified mRNA as a Treatment for Myocardial Infarction
Yu Wang, Wu Meiping, Haidong Guo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4737-4737
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top